ACAD vs SNA · P/E 15, rev $576.0M vs P/E 17, rev $1.33B
ACADIA Pharmaceuticals Inc (ACAD) versus Snap-On Inc (SNA) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Snap-On Inc (SNA) is a tools & accessories company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported SNA revenue for 2026-07-04 was $1.33B. Net income was $260.6M. Revenue was up 2.0% from 2026-04-04 to 2026-07-04. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. SNA currently screens at market cap $16.82B and trailing P/E 16.8.
Not investment advice. Open the ACAD and SNA stock pages for the full models.
Not investment advice.